1. |
Ip M, Hendrick A. Retinal vein occlusion review[J]. Asia Pac J Ophthalmol (Phila), 2017, 7(1): 40-45. DOI: 10.1364/oe.20.004710.
|
2. |
Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)[J]. Ophthalmologica, 2019, 242(3): 123-162. DOI: 10.1159/000502041.
|
3. |
Campa C, Alivernini G, Bolletta E, et al. Anti-VEGF therapy for retinal vein occlusions[J]. Curr Drug Targets, 2016, 17(3): 328-336. DOI: 10.2174/1573399811666150615151324.
|
4. |
Jia Y, Tan O, Tokayer J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography[J]. Opt Express, 2012, 20(4): 4710-4725. DOI: 10.1364/OE.20.004710.
|
5. |
Tsuboi K, Ishida Y, Kamei M. Gap in capillary perfusion on optical coherence tomography angiography associated with persistent macular edema in branch retinal vein occlusion[J]. Invest Ophthalmol Vis Sci, 2017, 58(4): 2038-2043. DOI: 10.1167/iovs.17-21447.
|
6. |
Yeung L, Wu WC, Chuang LH, et al. Novel optical coherence tomography angiography biomarker in branch retinal vein occlusion macular edema[J]. Retina, 2019, 39(10): 1906-1916. DOI: 10.1097/IAE.0000000000002264.
|
7. |
Mastropasqua R, Toto L, Di Antonio L, et al. Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions[J/OL]. Sci Rep, 2017, 7: 40763[2017-01-18]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241684/. DOI: 10.1038/srep40763.
|
8. |
Hasegawa T, Takahashi Y, Maruko I, et al. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion[J]. Br J Ophthalmol, 2018, 103(10): 1367-1372. DOI: 10.1136/bjophthalmol-2018-312769.
|
9. |
Tomita R, Iwase T, Goto K, et al. Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion [J/OL]. Sci Rep, 2019, 9(1): 16388[2018-11-08]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6841709/. DOI: 10.1038/s41598-019-52732-2.
|
10. |
Spaide RF. Retinal vascular cystoid macular edema: review and new theory[J]. Retina, 2016, 36(10): 1823-1842. DOI: 10.1097/IAE.0000000000001158.
|
11. |
Choi KE, Yun C, Cha J, et al. OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion[J/OL]. Sci Rep, 2019, 9(1): 14153[2019-10-02]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775095/. DOI: 10.1038/s41598-019-50637-8.
|
12. |
Sellam A, Glacet-Bernard A, Coscas F, et al. Qualitative and quantitative follow-up using optical coherence tomography angiography of retinal vein occlusion treated with anti-VEGF: optical coherence tomography angiography follow-up of retinal vein occlusion[J]. Retina, 2017, 37(6): 1176-1184. DOI: 10.1097/IAE.0000000000001334.
|
13. |
Koulisis N, Kim AY, Chu Z, et al. Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography[J/OL]. PLoS One, 2017, 12(4): e0176404[2017-04-24]. https://doi.org/10.1371/journal.pone.0176404. DOI: 10.1371/journal.pone.0176404.
|